世界の代謝障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Metabolic Disorders Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3715
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、代謝障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・代謝障害治療の市場動向
・企業の競争状況、市場シェア
・代謝障害治療の種類別市場規模（グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他）
・代謝障害治療の用途別市場規模（病院、小売薬局）
・代謝障害治療の北米市場規模2016-2027（アメリカ、カナダ）
・代謝障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・代謝障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・代謝障害治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・代謝障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck、Novartis、Takeda Pharmaceutical、Astra Zeneca、Boehringer Ingelheim、KOWA、Kythera、Fuji yakuhin、LG Life Science、Metsubishi Tanabe Pharma）
・結論

Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.

Market Analysis and Insights: Global Metabolic Disorders Treatment Market
The global Metabolic Disorders Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metabolic Disorders Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metabolic Disorders Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metabolic Disorders Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metabolic Disorders Treatment market.

Global Metabolic Disorders Treatment Scope and Market Size
Metabolic Disorders Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metabolic Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Glycogen Metabolism Disease Drug
Lipid Metabolism Disease Drug
Amino Acid Metabolism Drug
Other

Segment by Application
Hospital
Retail Pharmacy

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Boehringer Ingelheim
KOWA
Kythera
Fuji yakuhin
LG Life Science

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolic Disorders Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Glycogen Metabolism Disease Drug
1.2.3 Lipid Metabolism Disease Drug
1.2.4 Amino Acid Metabolism Drug
1.2.5 Other
1.3 Market by Application
1.3.1 Global Metabolic Disorders Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metabolic Disorders Treatment Market Perspective (2016-2027)
2.2 Metabolic Disorders Treatment Growth Trends by Regions
2.2.1 Metabolic Disorders Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metabolic Disorders Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Metabolic Disorders Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Metabolic Disorders Treatment Industry Dynamic
2.3.1 Metabolic Disorders Treatment Market Trends
2.3.2 Metabolic Disorders Treatment Market Drivers
2.3.3 Metabolic Disorders Treatment Market Challenges
2.3.4 Metabolic Disorders Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metabolic Disorders Treatment Players by Revenue
3.1.1 Global Top Metabolic Disorders Treatment Players by Revenue (2016-2021)
3.1.2 Global Metabolic Disorders Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Metabolic Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metabolic Disorders Treatment Revenue
3.4 Global Metabolic Disorders Treatment Market Concentration Ratio
3.4.1 Global Metabolic Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolic Disorders Treatment Revenue in 2020
3.5 Metabolic Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Metabolic Disorders Treatment Product Solution and Service
3.7 Date of Enter into Metabolic Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metabolic Disorders Treatment Breakdown Data by Type
4.1 Global Metabolic Disorders Treatment Historic Market Size by Type (2016-2021)
4.2 Global Metabolic Disorders Treatment Forecasted Market Size by Type (2022-2027)

5 Metabolic Disorders Treatment Breakdown Data by Application
5.1 Global Metabolic Disorders Treatment Historic Market Size by Application (2016-2021)
5.2 Global Metabolic Disorders Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metabolic Disorders Treatment Market Size (2016-2027)
6.2 North America Metabolic Disorders Treatment Market Size by Type
6.2.1 North America Metabolic Disorders Treatment Market Size by Type (2016-2021)
6.2.2 North America Metabolic Disorders Treatment Market Size by Type (2022-2027)
6.2.3 North America Metabolic Disorders Treatment Market Size by Type (2016-2027)
6.3 North America Metabolic Disorders Treatment Market Size by Application
6.3.1 North America Metabolic Disorders Treatment Market Size by Application (2016-2021)
6.3.2 North America Metabolic Disorders Treatment Market Size by Application (2022-2027)
6.3.3 North America Metabolic Disorders Treatment Market Size by Application (2016-2027)
6.4 North America Metabolic Disorders Treatment Market Size by Country
6.4.1 North America Metabolic Disorders Treatment Market Size by Country (2016-2021)
6.4.2 North America Metabolic Disorders Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Metabolic Disorders Treatment Market Size (2016-2027)
7.2 Europe Metabolic Disorders Treatment Market Size by Type
7.2.1 Europe Metabolic Disorders Treatment Market Size by Type (2016-2021)
7.2.2 Europe Metabolic Disorders Treatment Market Size by Type (2022-2027)
7.2.3 Europe Metabolic Disorders Treatment Market Size by Type (2016-2027)
7.3 Europe Metabolic Disorders Treatment Market Size by Application
7.3.1 Europe Metabolic Disorders Treatment Market Size by Application (2016-2021)
7.3.2 Europe Metabolic Disorders Treatment Market Size by Application (2022-2027)
7.3.3 Europe Metabolic Disorders Treatment Market Size by Application (2016-2027)
7.4 Europe Metabolic Disorders Treatment Market Size by Country
7.4.1 Europe Metabolic Disorders Treatment Market Size by Country (2016-2021)
7.4.2 Europe Metabolic Disorders Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metabolic Disorders Treatment Market Size (2016-2027)
8.2 Asia-Pacific Metabolic Disorders Treatment Market Size by Type
8.2.1 Asia-Pacific Metabolic Disorders Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metabolic Disorders Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metabolic Disorders Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Metabolic Disorders Treatment Market Size by Application
8.3.1 Asia-Pacific Metabolic Disorders Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metabolic Disorders Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metabolic Disorders Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Metabolic Disorders Treatment Market Size by Region
8.4.1 Asia-Pacific Metabolic Disorders Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metabolic Disorders Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metabolic Disorders Treatment Market Size (2016-2027)
9.2 Latin America Metabolic Disorders Treatment Market Size by Type
9.2.1 Latin America Metabolic Disorders Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Metabolic Disorders Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Metabolic Disorders Treatment Market Size by Type (2016-2027)
9.3 Latin America Metabolic Disorders Treatment Market Size by Application
9.3.1 Latin America Metabolic Disorders Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Metabolic Disorders Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Metabolic Disorders Treatment Market Size by Application (2016-2027)
9.4 Latin America Metabolic Disorders Treatment Market Size by Country
9.4.1 Latin America Metabolic Disorders Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Metabolic Disorders Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metabolic Disorders Treatment Market Size (2016-2027)
10.2 Middle East & Africa Metabolic Disorders Treatment Market Size by Type
10.2.1 Middle East & Africa Metabolic Disorders Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metabolic Disorders Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metabolic Disorders Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Metabolic Disorders Treatment Market Size by Application
10.3.1 Middle East & Africa Metabolic Disorders Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metabolic Disorders Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metabolic Disorders Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Metabolic Disorders Treatment Market Size by Country
10.4.1 Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Metabolic Disorders Treatment Introduction
11.1.4 Merck Revenue in Metabolic Disorders Treatment Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Metabolic Disorders Treatment Introduction
11.2.4 Novartis Revenue in Metabolic Disorders Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Metabolic Disorders Treatment Introduction
11.3.4 Takeda Pharmaceutical Revenue in Metabolic Disorders Treatment Business (2016-2021)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Details
11.4.2 Astra Zeneca Business Overview
11.4.3 Astra Zeneca Metabolic Disorders Treatment Introduction
11.4.4 Astra Zeneca Revenue in Metabolic Disorders Treatment Business (2016-2021)
11.4.5 Astra Zeneca Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Metabolic Disorders Treatment Introduction
11.5.4 Boehringer Ingelheim Revenue in Metabolic Disorders Treatment Business (2016-2021)
11.5.5 Boehringer Ingelheim Recent Development
11.6 KOWA
11.6.1 KOWA Company Details
11.6.2 KOWA Business Overview
11.6.3 KOWA Metabolic Disorders Treatment Introduction
11.6.4 KOWA Revenue in Metabolic Disorders Treatment Business (2016-2021)
11.6.5 KOWA Recent Development
11.7 Kythera
11.7.1 Kythera Company Details
11.7.2 Kythera Business Overview
11.7.3 Kythera Metabolic Disorders Treatment Introduction
11.7.4 Kythera Revenue in Metabolic Disorders Treatment Business (2016-2021)
11.7.5 Kythera Recent Development
11.8 Fuji yakuhin
11.8.1 Fuji yakuhin Company Details
11.8.2 Fuji yakuhin Business Overview
11.8.3 Fuji yakuhin Metabolic Disorders Treatment Introduction
11.8.4 Fuji yakuhin Revenue in Metabolic Disorders Treatment Business (2016-2021)
11.8.5 Fuji yakuhin Recent Development
11.9 LG Life Science
11.9.1 LG Life Science Company Details
11.9.2 LG Life Science Business Overview
11.9.3 LG Life Science Metabolic Disorders Treatment Introduction
11.9.4 LG Life Science Revenue in Metabolic Disorders Treatment Business (2016-2021)
11.9.5 LG Life Science Recent Development
11.10 Metsubishi Tanabe Pharma
11.10.1 Metsubishi Tanabe Pharma Company Details
11.10.2 Metsubishi Tanabe Pharma Business Overview
11.10.3 Metsubishi Tanabe Pharma Metabolic Disorders Treatment Introduction
11.10.4 Metsubishi Tanabe Pharma Revenue in Metabolic Disorders Treatment Business (2016-2021)
11.10.5 Metsubishi Tanabe Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metabolic Disorders Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Glycogen Metabolism Disease Drug
Table 3. Key Players of Lipid Metabolism Disease Drug
Table 4. Key Players of Amino Acid Metabolism Drug
Table 5. Key Players of Other
Table 6. Global Metabolic Disorders Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Metabolic Disorders Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Metabolic Disorders Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Metabolic Disorders Treatment Market Share by Regions (2016-2021)
Table 10. Global Metabolic Disorders Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Metabolic Disorders Treatment Market Share by Regions (2022-2027)
Table 12. Metabolic Disorders Treatment Market Trends
Table 13. Metabolic Disorders Treatment Market Drivers
Table 14. Metabolic Disorders Treatment Market Challenges
Table 15. Metabolic Disorders Treatment Market Restraints
Table 16. Global Metabolic Disorders Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Metabolic Disorders Treatment Market Share by Players (2016-2021)
Table 18. Global Top Metabolic Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Disorders Treatment as of 2020)
Table 19. Ranking of Global Top Metabolic Disorders Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Metabolic Disorders Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Metabolic Disorders Treatment Product Solution and Service
Table 23. Date of Enter into Metabolic Disorders Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Metabolic Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Metabolic Disorders Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Metabolic Disorders Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Metabolic Disorders Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Metabolic Disorders Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Metabolic Disorders Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Metabolic Disorders Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Metabolic Disorders Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Metabolic Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Metabolic Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Metabolic Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Metabolic Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Metabolic Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Metabolic Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Metabolic Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Metabolic Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Metabolic Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Metabolic Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Metabolic Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Metabolic Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Metabolic Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Metabolic Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Metabolic Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Metabolic Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Metabolic Disorders Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Metabolic Disorders Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Metabolic Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Metabolic Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Metabolic Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Metabolic Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Metabolic Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Metabolic Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Metabolic Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Metabolic Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Metabolic Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Metabolic Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Metabolic Disorders Treatment Product
Table 66. Merck Revenue in Metabolic Disorders Treatment Business (2016-2021) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Metabolic Disorders Treatment Product
Table 71. Novartis Revenue in Metabolic Disorders Treatment Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Takeda Pharmaceutical Company Details
Table 74. Takeda Pharmaceutical Business Overview
Table 75. Takeda Pharmaceutical Metabolic Disorders Treatment Product
Table 76. Takeda Pharmaceutical Revenue in Metabolic Disorders Treatment Business (2016-2021) & (US$ Million)
Table 77. Takeda Pharmaceutical Recent Development
Table 78. Astra Zeneca Company Details
Table 79. Astra Zeneca Business Overview
Table 80. Astra Zeneca Metabolic Disorders Treatment Product
Table 81. Astra Zeneca Revenue in Metabolic Disorders Treatment Business (2016-2021) & (US$ Million)
Table 82. Astra Zeneca Recent Development
Table 83. Boehringer Ingelheim Company Details
Table 84. Boehringer Ingelheim Business Overview
Table 85. Boehringer Ingelheim Metabolic Disorders Treatment Product
Table 86. Boehringer Ingelheim Revenue in Metabolic Disorders Treatment Business (2016-2021) & (US$ Million)
Table 87. Boehringer Ingelheim Recent Development
Table 88. KOWA Company Details
Table 89. KOWA Business Overview
Table 90. KOWA Metabolic Disorders Treatment Product
Table 91. KOWA Revenue in Metabolic Disorders Treatment Business (2016-2021) & (US$ Million)
Table 92. KOWA Recent Development
Table 93. Kythera Company Details
Table 94. Kythera Business Overview
Table 95. Kythera Metabolic Disorders Treatment Product
Table 96. Kythera Revenue in Metabolic Disorders Treatment Business (2016-2021) & (US$ Million)
Table 97. Kythera Recent Development
Table 98. Fuji yakuhin Company Details
Table 99. Fuji yakuhin Business Overview
Table 100. Fuji yakuhin Revenue in Metabolic Disorders Treatment Business (2016-2021) & (US$ Million)
Table 101. Fuji yakuhin Recent Development
Table 102. LG Life Science Company Details
Table 103. LG Life Science Business Overview
Table 104. LG Life Science Metabolic Disorders Treatment Product
Table 105. LG Life Science Revenue in Metabolic Disorders Treatment Business (2016-2021) & (US$ Million)
Table 106. LG Life Science Recent Development
Table 107. Metsubishi Tanabe Pharma Company Details
Table 108. Metsubishi Tanabe Pharma Business Overview
Table 109. Metsubishi Tanabe Pharma Metabolic Disorders Treatment Product
Table 110. Metsubishi Tanabe Pharma Revenue in Metabolic Disorders Treatment Business (2016-2021) & (US$ Million)
Table 111. Metsubishi Tanabe Pharma Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metabolic Disorders Treatment Market Share by Type: 2020 VS 2027
Figure 2. Glycogen Metabolism Disease Drug Features
Figure 3. Lipid Metabolism Disease Drug Features
Figure 4. Amino Acid Metabolism Drug Features
Figure 5. Other Features
Figure 6. Global Metabolic Disorders Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Metabolic Disorders Treatment Report Years Considered
Figure 10. Global Metabolic Disorders Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Metabolic Disorders Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Metabolic Disorders Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Metabolic Disorders Treatment Market Share by Regions (2022-2027)
Figure 14. Global Metabolic Disorders Treatment Market Share by Players in 2020
Figure 15. Global Top Metabolic Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Disorders Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Metabolic Disorders Treatment Revenue in 2020
Figure 17. Global Metabolic Disorders Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Metabolic Disorders Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Metabolic Disorders Treatment Market Share by Type (2016-2027)
Figure 21. North America Metabolic Disorders Treatment Market Share by Application (2016-2027)
Figure 22. North America Metabolic Disorders Treatment Market Share by Country (2016-2027)
Figure 23. United States Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Metabolic Disorders Treatment Market Share by Type (2016-2027)
Figure 27. Europe Metabolic Disorders Treatment Market Share by Application (2016-2027)
Figure 28. Europe Metabolic Disorders Treatment Market Share by Country (2016-2027)
Figure 29. Germany Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Metabolic Disorders Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Metabolic Disorders Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Metabolic Disorders Treatment Market Share by Region (2016-2027)
Figure 39. China Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Metabolic Disorders Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Metabolic Disorders Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Metabolic Disorders Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Metabolic Disorders Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Metabolic Disorders Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Metabolic Disorders Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Metabolic Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Merck Revenue Growth Rate in Metabolic Disorders Treatment Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Metabolic Disorders Treatment Business (2016-2021)
Figure 60. Takeda Pharmaceutical Revenue Growth Rate in Metabolic Disorders Treatment Business (2016-2021)
Figure 61. Astra Zeneca Revenue Growth Rate in Metabolic Disorders Treatment Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Metabolic Disorders Treatment Business (2016-2021)
Figure 63. KOWA Revenue Growth Rate in Metabolic Disorders Treatment Business (2016-2021)
Figure 64. Kythera Revenue Growth Rate in Metabolic Disorders Treatment Business (2016-2021)
Figure 65. Fuji yakuhin Revenue Growth Rate in Metabolic Disorders Treatment Business (2016-2021)
Figure 66. LG Life Science Revenue Growth Rate in Metabolic Disorders Treatment Business (2016-2021)
Figure 67. Metsubishi Tanabe Pharma Revenue Growth Rate in Metabolic Disorders Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の代謝障害治療市場規模・現状・予測（2021年-2027年）

Global Metabolic Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3715 2021年4月 97Pages
QYResearch社発行の本調査資料では、代謝障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、ア...

世界の代謝障害治療市場規模・現状・予測（2021年-2027年）

Global Metabolic Disorders Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3714 2021年4月 97Pages
QYResearch社発行の本調査資料では、代謝障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（異染性白質ジストロフィー、球状白質ジストロフィー、肝性脳症、その他）、用途別市場規模（糖尿病、肥満、高コレステロール血症、リソソーム蓄積症、...

世界の代謝障害治療市場規模・現状・予測（2021年-2027年）

世界のペプチドベース代謝障害治療薬市場規模・現状・予測（2021年-2027年）

Global Peptide Based Metabolic Disorders Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4501 2021年4月 94Pages
QYResearch社発行の本調査資料では、ペプチドベース代謝障害治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エキセナチド、リラグルチド、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、...

世界の代謝性疾患治療市場規模・現状・予測（2021年-2027年）

Global Metabolic Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3713 2021年4月 91Pages
QYResearch社発行の本調査資料では、代謝性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他）、用途別市場規模（病院薬局、小売薬局）、主要地域別市場規模（北...

世界の筋骨格系障害治療市場規模・現状・予測（2021年-2027年）

Global Musculoskeletal Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3975 2021年4月 97Pages
QYResearch社発行の本調査資料では、筋骨格系障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東...

世界の神経精神障害＆治療市場規模・現状・予測（2021年-2027年）

Global Neuropsychiatric Disorders and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4097 2021年4月 97Pages
QYResearch社発行の本調査資料では、神経精神障害＆治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、ショック治療、その他）、用途別市場規模（病院、診療所、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の双極性障害治療市場規模・現状・予測（2021年-2027年）

Global Bipolar Disorders and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0855 2021年4月 95Pages
QYResearch社発行の本調査資料では、双極性障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0523 2021年4月 91Pages
QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ブリッジ療法、組換え技術、糞便細菌療法、造血幹細胞移植、光線療法、寄生虫療法、活性化誘導アッセイ、飛行時間型質量分析サイトメトリー）、用...

世界の甲状腺障害治療市場規模・現状・予測（2021年-2027年）

Global Thyroid Gland Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5653 2021年4月 98Pages
QYResearch社発行の本調査資料では、甲状腺障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（甲状腺機能低下症、甲状腺機能亢進症）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の代謝障害治療市場規模・現状・予測（2021年-2027年） Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc. Market Analysis and Insights: Global Metabolic Disorders Treatment Market The global Metabol…
世界のアミノ酸代謝異常治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Amino Acid Metabolism Disorders Treatment Market The global Amino Acid Metabolism Disorders Treatment market size is projected to reach US$ 789.2 million by 2026, from US$ 547 million in 2019, at a CAGR of 5.3% during 2021-2026. With industry-standard accuracy in…
世界のアミノ酸代謝疾患治療市場規模・現状・予測（2021年-2027年） Amino Acid Metabolism Drug is used to treat the gout and Hyperuricemia. Market Analysis and Insights: Global Amino Acid Metabolism Disease Treatment Market The global Amino Acid Metabolism Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a C…
世界の代謝性疾患治療市場規模・現状・予測（2021年-2027年） Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc. Market Analysis and Insights: Global Metabolic Disease Treatment Market The global Metabolic Disease Treatment market size is projected to reach US$ XX million…
世界のグリコーゲン代謝性疾患治療市場規模・現状・予測（2021年-2027年） Diabetes mellitus is the main disease of Glycogen Metabolism Disease. Market Analysis and Insights: Global Glycogen Metabolism Disease Treatment Market The global Glycogen Metabolism Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of…